Bispecific antibodies for viral immunotherapy

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies. While the bispecific antibody approach has been applied widely to targets for indications such as cancer and inflammation, the development of such agents for viral immunotherapy is only now emerging. Here, we review recent advances in the development of bispecific antibodies for viral immunotherapy, highlighting promising in vitro and in vivo results.

Original languageEnglish (US)
Pages (from-to)836-842
Number of pages7
JournalHuman vaccines & immunotherapeutics
Volume13
Issue number4
DOIs
StatePublished - Apr 3 2017

Fingerprint

Bispecific Antibodies
Immunotherapy
Epitopes
Monoclonal Antibodies
Inflammation
Neoplasms

Keywords

  • antibody engineering
  • antibody therapeutics
  • antiviral
  • bifunctional antibodies
  • bispecific antibodies
  • immunotherapy
  • passive immunization
  • virology

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Bispecific antibodies for viral immunotherapy. / Nyakatura, Elisabeth K.; Soare, Alexandra Y.; Lai, Jonathan R.

In: Human vaccines & immunotherapeutics, Vol. 13, No. 4, 03.04.2017, p. 836-842.

Research output: Contribution to journalReview article

@article{02b653c323dc482685668d798b2fd04f,
title = "Bispecific antibodies for viral immunotherapy",
abstract = "Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies. While the bispecific antibody approach has been applied widely to targets for indications such as cancer and inflammation, the development of such agents for viral immunotherapy is only now emerging. Here, we review recent advances in the development of bispecific antibodies for viral immunotherapy, highlighting promising in vitro and in vivo results.",
keywords = "antibody engineering, antibody therapeutics, antiviral, bifunctional antibodies, bispecific antibodies, immunotherapy, passive immunization, virology",
author = "Nyakatura, {Elisabeth K.} and Soare, {Alexandra Y.} and Lai, {Jonathan R.}",
year = "2017",
month = "4",
day = "3",
doi = "10.1080/21645515.2016.1251536",
language = "English (US)",
volume = "13",
pages = "836--842",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Bispecific antibodies for viral immunotherapy

AU - Nyakatura, Elisabeth K.

AU - Soare, Alexandra Y.

AU - Lai, Jonathan R.

PY - 2017/4/3

Y1 - 2017/4/3

N2 - Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies. While the bispecific antibody approach has been applied widely to targets for indications such as cancer and inflammation, the development of such agents for viral immunotherapy is only now emerging. Here, we review recent advances in the development of bispecific antibodies for viral immunotherapy, highlighting promising in vitro and in vivo results.

AB - Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies. While the bispecific antibody approach has been applied widely to targets for indications such as cancer and inflammation, the development of such agents for viral immunotherapy is only now emerging. Here, we review recent advances in the development of bispecific antibodies for viral immunotherapy, highlighting promising in vitro and in vivo results.

KW - antibody engineering

KW - antibody therapeutics

KW - antiviral

KW - bifunctional antibodies

KW - bispecific antibodies

KW - immunotherapy

KW - passive immunization

KW - virology

UR - http://www.scopus.com/inward/record.url?scp=85021308971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021308971&partnerID=8YFLogxK

U2 - 10.1080/21645515.2016.1251536

DO - 10.1080/21645515.2016.1251536

M3 - Review article

C2 - 27786606

AN - SCOPUS:85021308971

VL - 13

SP - 836

EP - 842

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 4

ER -